Europe

Mar 11, 2010
By Pharmaceutical Executive Editors
Having a 'maverick' in your company can lead to problems as well as breakthroughs and innovations. Judith Germain outlines the value of harnessing a brilliant but wayward talent.
Mar 11, 2010
By Pharmaceutical Executive Editors
Open innovation is sometimes chaotic and often difficult to measure, but getting it right can give firms a real edge now and in the future.
Feb 26, 2010
By Pharmaceutical Executive Editors
A corporate focus on negotiation can help organizations reap substantial and measurable benefit, writes Alison Morris.
Feb 26, 2010
By Pharmaceutical Executive Editors
Anirban Ghosh and Siddharth Sawhney explain how research informatics tools can advance the speed and success of drug discovery research.
Feb 18, 2010
By Pharmaceutical Executive Editors
Marketing excellence programmes are popular, important and frequently flawed, says Dr Brian D. Smith
Feb 01, 2010
From Pharmaceutical Technology Europe
By Pharmaceutical Executive Editors
Although representing a huge market, the EU also presents problems that hamper profitability— particularly when it comes to differing price regulations across member states.
Jan 13, 2010
By Pharmaceutical Executive Editors
Dr Kay Wardle of RSA examines the impact of short-term survival strategies on pre-clinical R&D organizations.
Dec 17, 2009
By Pharmaceutical Executive Editors
Quintiles' Jim Featherstone asks what the end of the blockbuster generation means for the sales operation?s business model and how pharma should react to the transition.
Nov 30, 2009
By Pharmaceutical Executive Editors
David Sun of InterbrandHealth looks at global pharma branding trends for 2010 and beyond.
Nov 02, 2009
Reflector reports on how the European pharma commitees and national associations are trying to shape the upcoming pharmaceutical package through informal
native1_300x100
lorem ipsum